Works matching IS 09024441 AND DT 2022 AND VI 109 AND IP 4
Results: 14
Efficacy and safety of regimens used for the treatment of multicentric Castleman disease: A systematic review.
- Published in:
- European Journal of Haematology, 2022, v. 109, n. 4, p. 309, doi. 10.1111/ejh.13823
- By:
- Publication type:
- Article
Bone marrow CD3<sup>+</sup>CD56<sup>+</sup> regulatory T lymphocytes (T<sub>R3</sub><sub>−56</sub> cells) are inversely associated with activation and expansion of bone marrow cytotoxic T cells in IPSS‐R very‐low/low risk MDS patients.
- Published in:
- European Journal of Haematology, 2022, v. 109, n. 4, p. 398, doi. 10.1111/ejh.13822
- By:
- Publication type:
- Article
Real‐world study on adoption of standard‐of‐care for transplant‐eligible newly diagnosed multiple myeloma patients between 2017 and 2020/2021 across France, Germany, Spain, and Italy.
- Published in:
- European Journal of Haematology, 2022, v. 109, n. 4, p. 388, doi. 10.1111/ejh.13821
- By:
- Publication type:
- Article
Management of infection prophylaxis in Dutch patients with myelodysplastic syndromes, a web‐based case vignette questionnaire: The MINDSET study.
- Published in:
- European Journal of Haematology, 2022, v. 109, n. 4, p. 381, doi. 10.1111/ejh.13820
- By:
- Publication type:
- Article
Carfilzomib plus dexamethasone in patients with relapsed and refractory multiple myeloma: A retro‐prospective observational study.
- Published in:
- European Journal of Haematology, 2022, v. 109, n. 4, p. 373, doi. 10.1111/ejh.13819
- By:
- Publication type:
- Article
Early report on the severity of COVID‐19 in hematologic patients infected with the SARS‐CoV2 omicron variant.
- Published in:
- European Journal of Haematology, 2022, v. 109, n. 4, p. 364, doi. 10.1111/ejh.13818
- By:
- Publication type:
- Article
Safety and efficacy of apixaban and rivaroxaban in obese patients with acute venous thrombosis/embolism.
- Published in:
- European Journal of Haematology, 2022, v. 109, n. 4, p. 409, doi. 10.1111/ejh.13817
- By:
- Publication type:
- Article
The burden of illness of patients with paroxysmal nocturnal haemoglobinuria receiving C5 inhibitors in France, Germany and the United Kingdom: Patient‐reported insights on symptoms and quality of life.
- Published in:
- European Journal of Haematology, 2022, v. 109, n. 4, p. 351, doi. 10.1111/ejh.13816
- By:
- Publication type:
- Article
Early‐ and late‐onset posttransplant lymphoproliferative disorders among adult kidney and liver transplant recipients.
- Published in:
- European Journal of Haematology, 2022, v. 109, n. 4, p. 343, doi. 10.1111/ejh.13815
- By:
- Publication type:
- Article
Ph‐like gene alterations and complex chromosomal abnormalities are frequent in patients with acute lymphoblastic leukemia experiencing relapse after allogeneic hematopoietic cell transplantation.
- Published in:
- European Journal of Haematology, 2022, v. 109, n. 4, p. 406, doi. 10.1111/ejh.13814
- By:
- Publication type:
- Article
Survival and risk of vascular complications in myelofibrosis—A population‐based study from the Swedish MPN group.
- Published in:
- European Journal of Haematology, 2022, v. 109, n. 4, p. 336, doi. 10.1111/ejh.13813
- By:
- Publication type:
- Article
Assessment of agreement between EXTEM and NATEM thromboelastometry measurement assays in critically ill neonates.
- Published in:
- European Journal of Haematology, 2022, v. 109, n. 4, p. 327, doi. 10.1111/ejh.13812
- By:
- Publication type:
- Article
Prevalence of venous thromboembolism and its associations in a large racially homogenous population of sickle cell disease patients.
- Published in:
- European Journal of Haematology, 2022, v. 109, n. 4, p. 321, doi. 10.1111/ejh.13811
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- European Journal of Haematology, 2022, v. 109, n. 4, p. 307, doi. 10.1111/ejh.13660
- Publication type:
- Article